Antibacterial activity of stilbene oligomers against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics

Biocontrol Science

Volumn 12, Issue 1, 2007, Pages 7-14

  Sakagami, Yoshikazu ^a   Sawabe, Akiyoshi ^c   Komemushi, Sadao ^a   Ali, Zulfiqar ^b   Tanaka, Toshiyuki ^b   Iliya, Ibrahim ^b   Iinuma, Munekazu ^b  

^a KINKI UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c NONE

Author keywords

Antibacterial activity; MRSA; Stilbene oligomers; Synergism; VRE

Indexed keywords

ANTIBIOTICS; BACTERIA; DISEASES;

ANTIBACTERIAL ACTIVITY; MRSA INFECTIONS; STILBENE OLIGOMERS; SYNERGISM;

OLIGOMERS;

ANTIBIOTIC AGENT; OLIGOMER; STILBENE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

GNETUM; GNETUM GNEMON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 34047130784     PISSN: 13424815     EISSN: None     Source Type: Journal    
DOI: 10.4265/bio.12.7     Document Type: Article

References (40)

1. Atef, M., Abdel Hamid, S.E., and Abdel Ghani, M. (1979) The influence of diethylstilbestrol on the antibacterial activity in vitro of some antibiotics. Zentralbl. Veterinarmed. A., 26, 709-714.
2. Barie, P.S. (1998) Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J. Surg., 22, 118-26.
3. Bartley, P.B., Schooneveldt, J.M., Looke, D.F., Morton, A., Johnson, D.W., and Nimmo, G.R. (2001) The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital., J Hosp Infect., 48, 43-54.
4. de la Cal, M.A., Cerda, E., van Saene, H.K., Garcia-Hierro, P., Negro, E., Parra, M.L, Arias, S., and Ballesteros, D. (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit., J Hosp Infect., 56, 175-183.
5. Calfee, D.P., Giannetta, E.T., Durbin, L.J., Germanson, T.P., and Farr, B.M. (2003) Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin. Infect. Dis., 37, 326-332.
6. Coolson, B. (1995) Aspects of the epidemiology of MRSA in Europe. J. Chemother., 78 (suppl.3), 93-98.
7. Cox, R.A., Conquest, C., Mallaghan, C., and Marples, R.R. (1995) A major outbreak of methicillin resistant Staphylococcus aureus caused by a new phage-type (EMRSA). J. Hosp. Infect., 29, 87-106.
8. Didry, N., Dubreuil, L., and Pinkas, M. (1993) Microbiological properties of protoanemonin isolated from Ranunculus bulbosus. Phytother. Res., 7, 21-24.
9. Emori, T.G., and Gaynes R.P. (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Review, 6, 428-442.
10. Garner, J.S. (1996) Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect. Control Hosp. Epidemiol., 17, 53-80.
11. Goto, S., Yo, K., Kawakita, R., Kosakai, N., Mitsuhashi, S., Nishino, T., Ohsawa, N., and Tanami, H. (1981) Rerevision of the method of minimum inhibitory concentration (MIC). Chemotherapy, 29, 76-79.
12. Hanna, H., Umphrey, J., Tarrand, J., Mendoza, M., and Raad, I. (2001) Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect. Control Hosp. Epidemiol., 22, 217-219.
13. Hori, S. (2002) Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci (In Japanese). Nippon Rinsho, 60, 2144-2149.
14. Iinuma, M., Tosa, H., Tanaka, T., Asai, F., Kobayashi, Y., Shimano, R., and Miyauchi, K. (1996) Antibacterial activity xanthones from Guttiferaeous plants methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol., 48, 861-865.
15. Iliya, I., Tanaka, T., Iinuma, M.,Ali, A., Furusawa, M., Nakaya, K., Shirataki, Y., Murata, J., and Dornaedi, D. (2002a) Stilbene derivatives from two species of Gnetaceae. Chem. Pharm. Bull., 50, 796-801.
16. Iliya, I., Ali, Z., Tanaka, T., Iinuma, M., Furusawa, M., Nakaya, K., Murata, J., and Dornaedi, D. (2002b) Four new stilbene oligomers in the root of Gnetum gnemon. Helvet. Chim. Acata, 85, 2538-2546.
17. Inamori, Y., Ogawa, M., Nishiguchi, K., Koyama, S., Tsujibo, H., Miki, Y., and Takemura, S. (1991) Phytogrowth-inhibitory and antimicrobial activities of 3,4′-dihydroxy-alpha, beta-diethylstilbene, the isomer of diethylstilbestrol. Chem. Pharm. Bull., 39, 218-220.
18. Ito, T., Akao, Y., Yi, H., Ohguchi, K., Matsumoto, K., Tanaka, T., Iinuma,M., and Nozawa, Y. (2003) Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C, Carcinogenesis., 24, 1489-1497.
19. Kim, H.J., Chang, E.J., Bae, S.J., Shim, S.M., Park, H.D., Rhee, C.H., Park, J.H., and Choi, S.W. (2002) Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora. Arch. Pharm. Res., 25, 293-299.
20. Kotilainen, P., Routamaa, M., Peltonen, R., Evesti, P., Eerola, E., Salmenlinna, S., Vuopio-Varkila, J., Rossi, T. (2001) Eradication of methicillin resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch. Inter. Med., 161, 859-863.
21. Leclercq, R., and Courvalin, P. (1997) Resistance to glycopeptides in enterococci. Clinical Infect. Dis., 24, 545-556.
22. Moellering, R.C. (1998) Vancomycin-resistant enterococci. Clin. Infect. Dis., 26, 1196-1199.
23. Mohan, J, Gandhi, A.A., Bhavya, B.C., Rashmi, R., Karunagaran, D., Indu, R., Santhoshkumar, T.R. (2006) Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol. J. Biol. Chem., 281, 17599-17611.
24. Montecalvo, M.A., Jarvis, W.R., Uman, J., Shay, D.V., Petrullo, C., Rodney, K., Gedris, C., Horowitz, H.W., and Wormser, G.P. (1999) Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Annals Inter. Med., 131, 269-272.
25. Montecalvo, M.A., Jarvis, W.R., Uman, J., Shay, D.K., Petrullo, C., Horowitz, H.W., and Wormser, G.P. (2001) Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect. Control Hosp. Epidemiol., 22, 437-442.
26. Murry, B. (1997) Vancomycin-resistant enterococci. Am. J. Med., 101, 284-293.
27. Nagayama, A. (2006) Inactivation of influenza A virus by gentian violet (GV) and GV-dyed cotton cloth, and bactericidal activities of these agents. J. Infect. Chemother., 12, 73-79.
28. Nitta, T., Arai, T., Takamatsu, H., Inatomi, Y., Murata, H., Iinuma, M., Tanaka, T., Ito, T., Asai, F., Iliya, I., Nakanishi, T., and Watabe, K. (2002) Antibacterial activity of extracts prepared from tropical and subtropical plants on methicillin-resistant Staphylococcus aureus. J. Health Sci., 48, 273-276.
29. Nourse, C., Byrne, C., Murphy, H., Kaufman, M.E., Clarke, A., and Butler, K. (2000) Eradication of vancomycin-resistant Enterococcus faecium from a pediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol. Infect., 124, 53-59.
30. Sakagami, Y., Iinuma, M., Piyasena, K.G.N.P., and Dharmaratne, H.R.W. (2005) Antibacterial Activity of α-Mangostin against Vancomycin Resistant Enterococci (VRE) and Synergism with Antibiotics. Phytomedicine, 12, 203-208.
31. Sato, M., Tsuchiya, H., Takase, H., Kureshiro, H., Tanigaki, S., and Iinuma, M. (1995) Antibacterial activity of flavanone isolated from Sophora exigua against Methicillin-resistant Staphylococcus aureus and its combination with antibiotics. Phytother. Res., 9, 509-512.
32. Shaikh, Z.H., Osting, C.A., Hanna, H.A., Arbuckle, R.B., Tarr, J.J., and Raad, I.I. (2002) Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J. Hosp. Infect., 51, 52-58.
33. Slaughter, S., Hayden, M.K., Nathan, C, Hu, T.C., Rice, T., Van Voorhis, J., Matushek, M., Franklin, C., and Weinstein, R.A. (1996) A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Annals Inter. Med., 125, 448-456.
34. Venkateswarlu, S., Raju, M.S., and Subbaraju, G.V. (2002) Synthesis and biological activity of isoamoenylin, a metabolite of Dendrobium amoenum. Biosci. Biotechnol. Biochem., 66, 2236-2238.
35. Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V.T., and Braveny, I. (1994) Methicillin resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol., 3, 50-55.
36. Warren, D.K., Nitin, A., Hill, C., Fraser,V.J., and Kollef, M.H. (2004) Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect. Control Hosp. Epidemiol., 25, 99-104.
37. Williamson, E.M. (2001) Synergy and other interactions in phytomedicines. Phytomedicine, 8, 401-409.
38. Working Party Report (1998) Revised guideline for the control of methicillin resistant Staphylococcus aureus infection in hospitals. J. Hosp. Infect., 39, 253-255.
39. Wyrzykiewicz, E., Prukala, W., and Kedzia, B. (1994) Synthesis and antimicrobial properties of N-substituted derivatives of (E)-alpha-(or gamma)- azastilbenols. Farmaco, 49, 127-131.
40. Wyrzykiewicz, E., Blaszczyk, A., and Kedzia, B. (2000) Synthesis and antimicrobial activity of (E)-acetoxystilbenes and alpha, alpha- dibromoacetoxybibenzyls. Farmaco., 55, 151-157.